The platform, out loud.
ALL PAPERS – FEATURES – RESEARCH – PRESS RELEASES – CLINICAL – COMPANY
Ibumix Launches the ‘The Mix Platform’
Ibumix to Attend the Chemical Industry Awards 2026 in Manchester
Manchester, UK – June 2026
Ibumix is pleased to announce that we will be attending the Chemical Industry Awards 2026, organised by the Chemical Industries Association (CIA), on Thursday 18 June 2026 at the Kimpton Clocktower Hotel in Manchester. The awards celebrate excellence, innovation, and outstanding achievement across the UK chemical and pharmaceutical industries.
As a company focused on advancing liquid delivery technologies and enabling next-generation pharmaceutical products, Ibumix is excited to join industry leaders, innovators, researchers, and manufacturers from across the sector for this prestigious event.
The Chemical Industry Awards provide an important platform for recognising organisations and individuals who are driving scientific progress, sustainability, operational excellence, and innovation throughout the industry.
For Ibumix, the event represents an opportunity to engage with peers, exchange ideas, and celebrate the achievements of an industry that continues to play a vital role in improving lives through science and technology.
“We are looking forward to attending the CIA Awards and connecting with fellow innovators who are helping shape the future of the chemical and pharmaceutical sectors. Events such as these highlight the remarkable talent, creativity, and commitment that exist across our industry.”
The Ibumix team looks forward to meeting partners, collaborators, and industry colleagues during the event and celebrating the successes of the sector together.
Ibumix Attends the 17th Global DDF Summit in Berlin
Berlin, Germany — May 2026
Ibumix was proud to attend the 17th Global Drug Delivery & Formulation (DDF) Summit in Berlin, one of the pharmaceutical industry’s leading events focused on innovation in drug delivery, formulation science and next-generation therapeutics.
The summit brought together scientists, innovators, pharmaceutical leaders and technology pioneers from across the world to explore the future of medicine development and delivery. Across three days of presentations, discussions and networking, the event showcased cutting-edge advances shaping the next generation of pharmaceutical products and patient experiences.
For Ibumix, the event provided an excellent opportunity to connect with industry leaders and share perspectives on the future of formulation science and advanced delivery technologies.
George Forrest, Co-Founder and CEO of Ibumix, commented:
“The DDF Summit continues to be one of the most valuable forums for scientific exchange and innovation within the pharmaceutical sector. It was fantastic to engage with so many forward-thinking organisations and individuals who are driving the future of drug delivery.”
The summit also highlighted the growing industry focus on improving therapeutic performance, enhancing patient outcomes and developing more efficient and effective delivery systems — areas closely aligned with Ibumix’s mission to redefine formulation science.
Ibumix would like to thank the organisers for delivering an exceptional event, along with the speakers, attendees and industry partners who contributed to such insightful discussions throughout the week.
As Ibumix continues to advance its proprietary technology platform, the company looks forward to building on the relationships and conversations established during the summit.
We look forward to seeing the industry again next year.
DDFSummit #DrugDelivery #Formulation #Pharma #Ibumix